These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 12457252

  • 1. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED.
    Pediatr Cardiol; 2003; 24(2):122-6. PubMed ID: 12457252
    [Abstract] [Full Text] [Related]

  • 2. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 3. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China.
    Ruan Y, Ye B, Zhao X.
    Pediatr Infect Dis J; 2013 Oct; 32(10):e397-402. PubMed ID: 23722531
    [Abstract] [Full Text] [Related]

  • 4. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
    Sudo D, Monobe Y, Yashiro M, Sadakane A, Uehara R, Nakamura Y.
    Pediatr Int; 2010 Oct; 52(5):790-4. PubMed ID: 20487371
    [Abstract] [Full Text] [Related]

  • 5. Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease.
    Zhao CN, Du ZD, Gao LL.
    Chin Med J (Engl); 2016 Apr 20; 129(8):922-8. PubMed ID: 27064036
    [Abstract] [Full Text] [Related]

  • 6. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J, Liu P, Hu W, Xu Y, Deng J.
    Clin Rheumatol; 2021 Oct 20; 40(10):4191-4197. PubMed ID: 34059986
    [Abstract] [Full Text] [Related]

  • 7. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J.
    Eur J Pediatr; 2009 Nov 21; 168(11):1315-21. PubMed ID: 19159953
    [Abstract] [Full Text] [Related]

  • 9. Analysis of risk factors and prospective evaluation of cardiovascular complications of Kawasaki disease in children: a single centre study.
    Berdej-Szczot E, Firek-Pędras M, Szydłowski L, Krzystolik-Ładzińska J, Klimek K, Małecka-Tendera E.
    Kardiol Pol; 2013 Nov 21; 71(12):1279-86. PubMed ID: 23990228
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
    Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, Romano A, Bierman FZ.
    Arch Pediatr Adolesc Med; 2006 Jul 21; 160(7):686-90. PubMed ID: 16818833
    [Abstract] [Full Text] [Related]

  • 11. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
    Pediatr Infect Dis J; 2018 Oct 21; 37(10):976-980. PubMed ID: 29461447
    [Abstract] [Full Text] [Related]

  • 12. [Kawasaki disease in children--9 years experience].
    Kowalczyk M, Kawalec W, Daszkowska-York J, Turska-Kmieć A, Brzezińska-Rajszys G, Sobielarska D, Ziółkowska L, Kościesza A, Jagiełłowicz D, Mirecka-Rola A.
    Med Wieku Rozwoj; 2005 Oct 21; 9(2):179-93. PubMed ID: 16085959
    [Abstract] [Full Text] [Related]

  • 13. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
    Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.
    Kaohsiung J Med Sci; 2012 Jan 21; 28(1):23-9. PubMed ID: 22226058
    [Abstract] [Full Text] [Related]

  • 14. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
    Acta Paediatr; 2010 Oct 21; 99(10):1578-83. PubMed ID: 20491705
    [Abstract] [Full Text] [Related]

  • 15. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr 21; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 16. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.
    Michihata N, Matsui H, Fushimi K, Yasunaga H.
    Clin Pediatr (Phila); 2015 Oct 21; 54(11):1076-80. PubMed ID: 25573948
    [Abstract] [Full Text] [Related]

  • 17. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
    J Int Med Res; 2024 May 21; 52(5):3000605241252115. PubMed ID: 38713460
    [Abstract] [Full Text] [Related]

  • 18. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S.
    J Pediatr; 2000 Aug 21; 137(2):177-80. PubMed ID: 10931408
    [Abstract] [Full Text] [Related]

  • 19. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
    Wu Y, Wang S, Zhou Y, Yang Y, Li S, Yin W, Ding Y.
    PLoS One; 2023 Aug 21; 18(10):e0292653. PubMed ID: 37824465
    [Abstract] [Full Text] [Related]

  • 20. Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?
    Fabi M, Corinaldesi E, Pierantoni L, Mazzoni E, Landini C, Bigucci B, Ancora G, Malaigia L, Bodnar T, Di Fazzio G, Lami F, Valletta E, Cicero C, Biasucci G, Iughetti L, Marchetti F, Sogno Valin P, Amarri S, Brusa S, Sprocati M, Maggiore G, Dormi A, Lanzoni P, Donti A, Lanari M.
    PLoS One; 2018 Aug 21; 13(9):e0202658. PubMed ID: 30180185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.